The DOT1L inhibitor EPZ-5676: Safety and activity in relapsed/refractory patients with MLL-rearranged leukemia Meeting Abstract
| Authors: | Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Savona, M.; Tibes, R.; Altman, J. K.; Jongen-Lavrencic, M.; Döhner, H.; Armstrong, S.; Pollock, R. M.; Waters, N. J.; Legler, M.; Thomson, B.; Daigle, S.; McDonald, A.; Campbell, C.; Olhava, E.; Hedrick, E. E.; Löwenberg, B.; Copeland, R. A.; Tallman, M. S. |
| Abstract Title: | The DOT1L inhibitor EPZ-5676: Safety and activity in relapsed/refractory patients with MLL-rearranged leukemia |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349242704027 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.387.387 |
| Notes: | Meeting Abstract: 387 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
